# US 2025/0360248 A1 · Injectable gels comprising cross-linked hyaluronic acid and hydroxyapatite, and methods of manufacturing thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0360248 A1
- Document ID: US20250360248A1
- Status: Published application
- Kind: A1
- Application number: 19/030,334
- Filed: 2025-01-17
- Published: 2025-11-27
- Earliest claimed: 2016-09-07
- Assignees: Luminera Derm Ltd.
- Applicants: Luminera Derm Ltd.
- Inventors: David Dadi SEGAL; Eran GOLDBERG; Lital SHKLANOVSKY; Ariel ZINGER; Liat GOLDSHAID-ZMIRI
- Web page: https://patentgrep.com/patent/US20250360248A1

## CPC

- A61L 27/52: Hydrogels or hydrocolloids
- A61K 8/042: {Gels}
- A61K 8/24: Phosphorous; Compounds thereof
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/20: Polysaccharides
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61Q 19/08: Anti-ageing preparations
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/34: for soft tissue reconstruction
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Provided herein are the compositions and methods of manufacturing of injectable gels of cross-linked hyaluronic acid associated to a varying degree with hydroxyapatite.

## Claims

### Claim 1

A process of manufacturing of a gel product comprising cross-linked hyaluronic acid and hydroxyapatite, said process comprising:
combining in an aqueous medium hyaluronic acid or a salt thereof, a cross-linking agent, and conducting a cross-linking reaction in the presence of a first portion of hydroxyapatite;
completing the cross-linking reaction; and
incorporating a second portion of hydroxyapatite into the so-formed gel.

### Claim 2 (depends on 1)

The process according to claim 1, wherein said conducting a cross-linking reaction comprises increasing the pH of the medium, and said completing the cross-linking reaction comprises allowing the reaction mixture to stand, and/or neutralizing said reaction mixture.

### Claim 3 (depends on 1)

The process of claim 1, wherein said first portion of hydroxyapatite is between 5 and 90 weight percent of the total amount of hydroxyapatite.

### Claim 4 (depends on 1)

The process of claim 1, wherein said first portion of hydroxyapatite is between 5 and 30 weight percent of the total amount of hydroxyapatite.

### Claim 5 (depends on 1)

The process of claim 1, wherein said cross-linking agent is selected from the group consisting of 1,4-butanediol diglycidyl ether, poly-(ethylene glycol) diglycidyl ether, and ethylene glycol diglycidyl ether.

### Claim 6 (depends on 5)

The process of claim 5, wherein said cross-linking agent is 1,4-butanediol diglycidyl ether.

### Claim 7 (depends on 1)

The process of claim 1, wherein a concentration of said hyaluronic acid in said aqueous medium is between 0.2 and 9 weight percent.

### Claim 8 (depends on 7)

The process of claim 7, wherein a concentration of said hyaluronic acid in said aqueous medium is between 0.5-4.

### Claim 9 (depends on 1)

The process of claim 1, wherein a weight ratio between said hyaluronic acid and said cross-linking agent in said aqueous medium is between 15:1 and 2:1.

### Claim 10 (depends on 1)

The process of claim 1, further comprising introducing additional amount of hyaluronic acid to the gel after terminating the cross-linking reaction.

### Claim 11 (depends on 1)

The process of claim 1, wherein a concentration of hydroxyapatite in said gel is above 25 weight percent.

### Claim 12 (depends on 11)

The process of claim 11, wherein a concentration of hydroxyapatite in said gel is above 45 weight percent.

### Claim 13 (depends on 12)

The process of claim 12, wherein a concentration of hydroxyapatite in said gel is between 50 and 60 weight percent.

### Claim at position 14

-26. (canceled)

### Claim 27

A gel product comprising:
(i) cross-linked hyaluronic acid or a salt thereof,
(ii) hydroxyapatite, and
(iii) water,
wherein the concentration of said hydroxyapatite is above 45 weight percent of total weight of the gel.

### Claim 28 (depends on 27)

The gel product of claim 27, wherein the concentration of said hydroxyapatite is between 50 and 60 weight percent of total weight of the gel.

### Claim 29 (depends on 27)

The gel product of claim 27, wherein a portion of said hydroxyapatite is inseparable from said gel following centrifugation for 10 minutes under 735 g-force, said portion being at least about fifth of the total amount of hydroxyapatite.

### Claim 30 (depends on 27)

The gel product of claim 27, wherein the concentration of said cross-linked hyaluronic acid is between 0.2 and 9 weight percent.

### Claim 31 (depends on 27)

The gel product of claim 27, wherein said cross-linked hyaluronic acid is cross-linked with a structural unit corresponding to 1,4-butanediol diglycidyl ether, poly-(ethylene glycol) diglycidyl ether, or ethylene glycol diglycidylether.

### Claim 32 (depends on 27)

The gel product of claim 27, wherein the hydroxyapatite is calcium hydroxyapatite that has an average particle size between 25 and 45 micrometers.
